logo
logo

Abram Scientific Secures $1 Million National Science Foundation (Nsf) Small Business Innovation Research (Sbir) Phase Ii Grant

Apr 06, 2021•over 4 years ago
San Francisco

Description

Abram Scientific today announced it has secured $1 million in non-dilutive funding with an NSF SBIR Phase II Grant in support of the clinical development of the CoagCare System. The system is intended to aid in the evaluation of blood clotting disorders and help define appropriate treatment for patients undergoing trauma and surgical procedures in the hospital. This work is supported by America's Seed Fund powered by the NSF under Grant No. 2050272.

Company Information

Company

Abram

Location

San Francisco, California, United States

About

Based in the San Francisco Bay Area, Abram Scientific was founded by Dr. Abhishek Ramkumar who invented the CoagCare platform technology. The technology is covered by US and international patents and applications. Abram's leadership includes medical device industry veterans with >40 years experience: Dr. Edward Brennan, CEO and Mr. James Merselis, Chairman. Abram's CoagCare System is not yet cleared by the U.S. Food and Drug Administration for marketing in the United States.